A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a prospective, randomized, placebo-double-blind, multicenter clinical trial. The purpose of this study is to investigate whether \"butylphthalide +PCI\" combined treatment mode on the basis of traditional drug therapy could reduce myocardial infarct size, improve cardiac function and long-term prognosis of patients with acute myocardial infarction, and verify the drug safety of butylphthalide in the treatment of STEMI within the window period of 12 hours.
Epistemonikos ID: 6b3777647acb9b2b54abdb454ad6ba51de88a0a4
First added on: Dec 01, 2024